Drug screening and diagnosis based on paracrine tubular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/493 (2006.01) G01N 33/50 (2006.01) G01N 33/74 (2006.01)

Patent

CA 2342921

The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.

L'invention a trait à un procédé de criblage de médicaments utiles pour traiter l'hypertension au moyen du système de rénine-angiotensinogène tubulaire identifié par la présente invention. L'invention concerne en outre un procédé permettant de diagnostiquer un état pathologique lié au sodium et une sensibilité au sodium chez un sujet par la mesure d'angiotensinogène ou d'angiotensine I urinaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Drug screening and diagnosis based on paracrine tubular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug screening and diagnosis based on paracrine tubular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug screening and diagnosis based on paracrine tubular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1906271

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.